Hormone therapy poses stroke risk for transgender women

(Reuters Health) – Hormones given to people to align their sex with their gender pose a significant risk of serious blood clots and stroke among transgender women, one of the largest studies of transgender patients has concluded.

The risk of a dangerous type of blood clot, called a venous thromboembolism, nearly doubles for people transitioning from male to female compared to both non-transgender men and women, researchers reported in Annals of Internal Medicine.

The risk seems to come from hormone therapy. Among transgender women who had started the therapy, the clot risk was five-fold…

Read More Here

Be the first to comment on "Hormone therapy poses stroke risk for transgender women"

Leave a comment

Your email address will not be published.